Deep learning methods have been used to augment existing energy-based physical models in ‘do novo’ or from-scratch computational protein design, resulting in a 10-fold increase in success rates verified in the lab for binding a designed protein with its target protein. The results will help scientists design better drugs against diseases like cancer and COVID-19.
http://news.poseidon-us.com/StBjLJ
